Working… Menu

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, ccRCC and NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02771626
Recruitment Status : Completed
First Posted : May 13, 2016
Last Update Posted : February 2, 2021
Information provided by (Responsible Party):
Calithera Biosciences, Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2020
Actual Study Completion Date : June 2020
Certification/Extension First Submitted : January 29, 2021